Chemokine releasing particle implants for trapping circulating prostate cancer cells
Open Access
- 10 March 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Abstract
Prostate cancer (PCa) is the most prevalent cancer in U.S. men and many other countries. Although primary PCa can be controlled with surgery or radiation, treatment options of preventing metastatic PCa are still limited. To develop a new treatment of eradicating metastatic PCa, we have created an injectable cancer trap that can actively recruit cancer cells in bloodstream. The cancer trap is composed of hyaluronic acid microparticles that have good cell and tissue compatibility and can extend the release of chemokines to 4 days in vitro. We find that erythropoietin (EPO) and stromal derived factor-1α can attract PCa in vitro. Animal results show that EPO-releasing cancer trap attracted large number of circulating PCa and significantly reduced cancer spreading to other organs compared with controls. These results support that cancer trap may serve as a unique device to sequester circulating PCa cells and subsequently reduce distant metastasis.Keywords
Funding Information
- U.S. Department of War (W81XWH-14-1-0289, W81XWH-14-1-0289, W81XWH-14-1-0289, W81XWH-14-1-0289)
This publication has 77 references indexed in Scilit:
- The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasisBiomaterials, 2012
- Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobesBiomaterials, 2011
- Biomaterial implants mediate autologous stem cell recruitment in miceActa Biomaterialia, 2011
- Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2Acta Biomaterialia, 2011
- The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory responseBiomaterials, 2010
- Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite CapabilitiesAngewandte Chemie International Edition, 2009
- Peptide-Functionalized Nanogels for Targeted siRNA DeliveryBioconjugate Chemistry, 2009
- Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathwayBiochemical and Biophysical Research Communications, 2009
- Structural Analysis and Mechanical Characterization of Hyaluronic Acid-Based Doubly Cross-Linked NetworksMacromolecules, 2009
- Osteoblasts in prostate cancer metastasis to boneNature Reviews Cancer, 2005